A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
Public ClinicalTrials.gov record NCT00696384. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 8-Month Phase 3, Open-Label Study With a Blinded Reversal Phase to Evaluate the Safety and Tolerability of TAK-491 in Subjects With Essential Hypertension
Study identification
- NCT ID
- NCT00696384
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 418 participants
Conditions and interventions
Conditions
Interventions
- Azilsartan medoxomil Drug
- Azilsartan medoxomil, with or without chlorthalidone and other non-angiotensin II receptor blocker antihypertensive medications. Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2007
- Primary completion
- Mar 31, 2009
- Completion
- Mar 31, 2009
- Last update posted
- Jan 3, 2012
2007 – 2009
United States locations
- U.S. sites
- 33
- U.S. states
- 22
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Chandler | Arizona | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Tempe | Arizona | — | — |
| Not listed | Los Gatos | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | Tustin | California | — | — |
| Not listed | Westlake Village | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Wheat Ridge | Colorado | — | — |
| Not listed | Melbourne | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | South Bend | Indiana | — | — |
| Not listed | Auburn | Maine | — | — |
| Not listed | Marlborough | Massachusetts | — | — |
| Not listed | Chelsea | Michigan | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Trenton | New Jersey | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Burlington | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Carlisle | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Mt. Pleasant | South Carolina | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Lakewood | Washington | — | — |
| Not listed | Renton | Washington | — | — |
| Not listed | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00696384, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 3, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00696384 live on ClinicalTrials.gov.